STOP T1D

09/26/2025

The UK is taking a vigorous approach to engaging individuals and their families after screenings reveal the presence of T1D autoantibodies, which signals the risk of progression to clinical .

TEDDY and Fr1da studies are cited:

"As may be expected, there is an increase in psychological distress (anxiety, depression) when parents (particularly maternal caregivers) are given the news that their child is IAb positive; although in the Fr1da study, psychological distress (depression) seen in parents of IAb positive children returned to baseline within 6–12 months.9 However, in the TEDDY study, anxiety levels in parents of children identified as genetically at-risk only reduced if they were informed that their child was IAb negative. Dropout rates after the first IAb screen can be as high as 50%. The benefits of screening programmes (DKA reduction) are only seen in the context of active monitoring, rather than screening alone. A monitoring programme that is practical and encourages engagement is crucial. It is unclear what the long-term effect is of living with the knowledge of risk, for example, the impact on lifestyle, behaviour and mood; and research is underway to address these knowledge gaps."

Diabetic Medicine | Diabetes UK Journal | Wiley Online Library https://onlinelibrary.wiley.com/doi/10.1111/dme.70117

Health care providers interested in learning more about T1D screenings, diagnoses, and monitoring should review STOP T1D's free online course. Visit stopt1dprogram.org/for-hcp to learn more and register.

Screening for childhood type 1 diabetes (T1D) is increasing worldwide. Historically, screening has been undertaken through research programmes, but increasingly in the UK, children and young people a...

09/25/2025

HCPs and T1D researchers, your feedback is requested...

"A new draft consensus report from the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) updates the 2021 guidance on managing ( ) in adults, with revisions to diagnostic criteria, recommendations on diabetes technology, and strategies for addressing obesity.

“'We want everybody to send comments, to get as large and wide input as we can, because this is about people and their lives,'" Anne L. Peters, MD, professor of clinical medicine at Keck School of Medicine, University of Southern California, Los Angeles

EASD/ADA Draft Updates Type 1 Diabetes Management Guidance https://www.medscape.com/viewarticle/easd-ada-draft-updates-type-1-diabetes-management-guidance-2025a1000phl

The draft EASD/ADA Type 1 Diabetes Management Guidance document adds new information about diagnosing T1D in adults as well as obesity management, technology, and complications screening.

09/24/2025

Know the signs and symptoms of type 1 diabetes!

The most common T1D symptoms include:
1.) Extreme thirst
2.) Unexplained weight loss
3.) Frequent urination/ bedwetting
4.) Unexplained fatigue/ weakness
5.) Change in appetite

To learn more, visit BarbaraDavisCenter.org and STOPT1Dprogram.org.

09/23/2025

‼️ Ask the Experts' Mini-Fellowship starts in just 2 days! Have you registered yet? There's still time ‼️

Health Care Providers: This Ask the Experts' mini-fellowship offered by the physicians and researchers at the Barbara Davis Center for Diabetes at the University of Colorado, Anschutz Medical Campus.

IN-PERSON One-Day Event: Thursday, September 25 | 9:00 AM – 4:00 PM
The Alliance Center in downtown Denver

**See the event agenda on the image below**

Why Attend?
Most children who develop type 1 diabetes (T1D) show no warning signs—until diabetic ketoacidosis strikes. This fast-paced, evidence-rich course equips pediatricians with the latest tools to spot the silent stage of T1D, differentiate it from early type 2, and act before an emergency unfolds.

Who Should Attend?
Pediatricians, family physicians, and allied clinicians who manage children and adolescents in any primary-care setting.

Learn More and Reserve Your Seat
Space is limited to ensure hands-on interaction.
This FREE event is supported by: The Leona M. and Harry B. Helmsley Charitable Trust

Register: https://www.asktheexperts.org//mini-fellowship (asktheexperts. org/mini-fellowship)

Free Credit
The University of Colorado School of Medicine is accredited by the Accreditation Council for Continuing Medical Education ( ) to provide continuing medical education for physicians.

The University of Colorado School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 Credits.™ Physicians should claim only the credit commensurate with the extent of their participation in the activity.

09/23/2025

New research report on the risks of dementia among the population...

"The risk of all-cause dementia and dementia subtypes is higher in individuals with type 1 diabetes compared with matched controls."

Dementia Risk in People With and Associated Risk Factors: A Nationwide, Register-Based Cohort Study > https://diabetesjournals.org/care/article-abstract/doi/10.2337/dc25-0773/163118/Dementia-Risk-in-People-With-Type-1-Diabetes-and?redirectedFrom=fulltext

OBJECTIVE. Life expectancy of individuals with type 1 diabetes has increased, extending exposure to age-related conditions including dementia. Although ear

09/22/2025

Young people managing need more education on how to exercise for health benefits, without experiencing anxiety over "uncertainty of how exercise might affect their blood sugars during and after exercise."

"For youth with , access to education and support for exercising safely translates to improved glucose outcomes, even when MVPA [moderate-to-vigorous physical activity] time does not meet recommended guidelines. Even short bouts of vigorous activity provide a 24-h glucose-lowering effect that, if managed skillfully, can translate to improved overall glycemic management."

https://diabetesjournals.org/care/article/48/10/1719/163447/Physical-Activity-Support-Can-Improve-Outcomes-in

Physical activity guidelines recommend children and adolescents get ≥60 min of moderate-to-vigorous physical activity (MVPA) per day (1,2). Approximately o

09/19/2025

✅ Register Now to Attend!

8th Symposium on General Population Screening for T1D
November 10-11, 2025

In-Person (Denver, Colorado) and Virtual Event (Zoom)

The Symposium aims to explore the expanding evidence and current international efforts to identify pre-symptomatic T1D, emphasizing the potential benefits such as delayed progression and prevention of complications. Through expert panels and case studies, the event will also address the challenges of screening, monitoring and supporting children with early-stage T1D. The discussions will conclude with future directions for screening, highlighting the need for coordinated efforts and policy guidance.

This Symposium is for health care providers, including:

🔹 MDs
🔹 DOs
🔹 Nurses
🔹 Social Workers
🔹 Dieticians
🔹 Researchers in the area of screening, monitoring, and prevention of diabetes
🔹 Lay representatives of patient organizations
🔹 Representatives of funding agencies

⭐️ Up to 13.75 CME credits available to HCPs for full participation ⭐️

Learn More and Register at: https://bit.ly/BDC8thSymposium2025

**The event is FREE but requires registration—whether in-person or virtual**

 Target Audience: Healthcare professionals including MD, DO, advanced practice providers, nurses, social workers, and dieticians; researchers in the area of screening, monitoring, and prevention of diabetes; lay representatives of patient organizations and representatives of funding agencies.

09/18/2025

Catch up on the key takeaways from the conference in San Francisco.

ENDO 2025: The Gold Standard - Endocrine News https://endocrinenews.endocrine.org/endo-2025-the-gold-standard/

ENDO 2025 mines endocrine breakthroughs and breakouts in San Francisco When the biggest endocrinology conference in the world happens, professionals from around the world take notice! Over 7,000 endocrinologists from around the world hit the jackpot in San Francisco the second week in July for ENDO....

09/18/2025

Managing ? Keep a close watch on your blood glucose levels to help protect your vision.

"Severe hypoglycemia is linked to a higher rate of in patients with type 2 diabetes and proliferative disease in patients with the type 1 form of the condition. Previous research from scientists at Johns Hopkins found periods of may weaken the blood-retina barrier and promote leakage in the tissue, leading to loss of vision."

Hypoglycemia Tied to Risk for Diabetic Retinopathy: https://www.medscape.com/viewarticle/hypoglycemia-tied-risk-diabetic-retinopathy-2025a1000oft

Low blood glucose is linked to worsening eye disease in a new study.

09/16/2025

No doubt some parents of kids managing are wondering how mobile device restrictions being implemented at their schools may affect their access to important CGM data. Breakthrough T1D addresses this question...

"A 504 Plan is a legal, written document that specifies what reasonable modifications and accommodations the school must provide for a student with a disability, including type 1 diabetes. 504 Plans are a way for parents to hold the school accountable for meeting their child’s needs while in the school’s care."

"In many 504 Plans, the child’s cell phone will be classified as a medical device so that they can carry it with them during the school day for glucose monitoring or insulin dosing."

How school cell phone bans impact students with type 1 diabetes - Breakthrough T1D https://www.breakthrought1d.org/news-and-updates/cell-phone-bans-in-school/

For students with type 1 diabetes who use technology to manage the condition, school cell phone bans can present challenges.

09/15/2025

An learning opportunity in for and Care professionals coming up on Sept. 26, 2025.

Creative Solutions in Diabetes Care & Education https://www.adces.org/education/events/unlisted-detail/creative-solutions-to-diabetes-challenges

Hi! ADCES and danatech use cookies to make your experience on our platforms better and more personalized. By continuing to browse, you agree to our use of cookies to enhance your learning journey.

09/12/2025

Good information for parents and pediatricians helping children manage using the MiniMed™780G ...

"Switching to the recommended MiniMed™780G settings, driven primarily by AIT reduction in most patients, was safe and effective, improving glycemic control without increasing hypoglycemia. These findings support broader use of these settings in pediatric and young adult patient with type 1 diabetes."

Frontiers | Real-world efficacy of MiniMed™780G recommended settings (glycemic target 100 mg/dL, active insulin time 2 hours) in youth and young adults with type 1 diabetes https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2025.1670266/full

Background and aimsDespite growing evidence supporting the efficacy and safety of the MiniMed™ 780G recommended settings (Glucose Target 100 mg/dL and Active...